Clinical Trials in California

Showing 1021-1040 of 11,359 trials

RECRUITING63 miles

Objective Assessment of Intraocular Lens Tilt and Decentration

NCT07324200

Prospective, multi-center, non-interventional, open label, randomized clinical study.

Tilt and Decentration

Johnson & Johnson Surgical Vision, Inc.80 participantsStarted Mar 2026

Bakersfield, California, United States • Sioux City, Iowa, United States

COMPLETEDPhase 3117 miles

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

NCT02947347

This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study to evaluate the efficacy and safety of ibrutinib in combination with rituximab versus placebo in combination with rituximab in treatment naïve participants with follicular lymphoma (FL).

Follicular Lymphoma

Pharmacyclics LLC.445 participantsStarted Jan 2017

Mobile, Alabama, United States • Duarte, California, United States • Santa Barbara, California, United States +125 more locations

Objective Assessment of Intraocular Lens Tilt and Decentration

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Find Trials by Condition in California

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

An International Observational Study of Adults With Acute Infection

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Safety of RSV Preventive Monoclonal Antibody

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

Mucopolysaccharidosis VII Disease Monitoring Program

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)